Skip to main content

LCD L33436: Mohs Micrographic Surgery (MMS)

LCD L33436, Mohs Micrographic Surgery (MMS), is the Local Coverage Determination that Palmetto GBA applies to claims from 7 states (AL, GA, NC, SC, TN, VA, WV), effective 2023-11-16 and first in force 2015-10-01. The policy text runs 596 words, and its billing and coding article A56732 lists 176 ICD-10-CM codes that support medical necessity for 5 procedure codes. 5 other contractor versions share this title, so the criteria depend on where the service is furnished. Counting every linked billing and coding article, this one lists 176 covered ICD-10-CM codes: the same total as L35494 (Wisconsin Physicians Service Insurance Corporation, 176 codes, revised 2024-10-31) and 15 fewer codes than L33689 (First Coast Service Options, Inc., 191 codes, revised 2019-01-08).

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Palmetto GBA
States and territories
7
AL GA NC SC TN VA WV
Revision effective
2023-11-16
Original effective
2015-10-01
Policy text
596 words
Covered ICD-10 codes (articles)
176

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L33436
ContractContractorTypeStates
11202Palmetto GBAA and B and HHH MACSC
11302Palmetto GBAA and B and HHH MACVA
11402Palmetto GBAA and B and HHH MACWV
11502Palmetto GBAA and B and HHH MACNC
10112Palmetto GBAA and B MACAL
10212Palmetto GBAA and B MACGA
10312Palmetto GBAA and B MACTN

Billing and coding article A56732: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A56732 (Billing and Coding: Mohs Micrographic Surgery (MMS)) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A56732: Billing and Coding: Mohs Micrographic Surgery (MMS) (Billing and Coding, effective 2024-01-31)

Covered ICD-10-CM codes
176
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
5
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A56732
ICD-10-CMDescription (FY2027)
C00.0Malignant neoplasm of external upper lip
C00.1Malignant neoplasm of external lower lip
C00.3Malignant neoplasm of upper lip, inner aspect
C00.4Malignant neoplasm of lower lip, inner aspect
C00.5Malignant neoplasm of lip, unspecified, inner aspect
C00.6Malignant neoplasm of commissure of lip, unspecified
C00.8Malignant neoplasm of overlapping sites of lip
C30.0Malignant neoplasm of nasal cavity
C43.0Malignant melanoma of lip
C43.111Malignant melanoma of right upper eyelid, including canthus
C43.112Malignant melanoma of right lower eyelid, including canthus
C43.121Malignant melanoma of left upper eyelid, including canthus
C43.122Malignant melanoma of left lower eyelid, including canthus
C43.21Malignant melanoma of right ear and external auricular canal
C43.22Malignant melanoma of left ear and external auricular canal
C43.31Malignant melanoma of nose
C43.39Malignant melanoma of other parts of face
C43.4Malignant melanoma of scalp and neck
C43.52Malignant melanoma of skin of breast
C43.59Malignant melanoma of other part of trunk
C43.61Malignant melanoma of right upper limb, including shoulder
C43.62Malignant melanoma of left upper limb, including shoulder
C43.71Malignant melanoma of right lower limb, including hip
C43.72Malignant melanoma of left lower limb, including hip

Procedure codes: 17311, 17312, 17313, 17314, 17315.

Coverage indications, limitations and medical necessity

Medicare will consider reimbursement for Mohs micrographic surgery (MMS) for accepted diagnoses and indications. Current accepted diagnoses and indications are listed in this LCD. The physician performing the MMS must be trained and highly skilled in MMS techniques, and pathology identification. The physician must document in the patient's medical record that the diagnosis is appropriate for MMS and that MMS is the most appropriate choice as the treatment of the particular lesion.

Medicare is aware that a biopsy of the skin lesion for which Mohs surgery is planned is necessary in order for the physician to determine the exact nature of the lesion(s) to be removed. Occasionally, that biopsy may need to be done on the same day that the Mohs surgery is planned to be done.

No payment will be allowed for the biopsy and pathology of a lesion, which requires removal by the MMS technique, if a biopsy of that lesion has been performed within 60 days prior to MMS. An exception exists when a biopsy has been performed within that period and the biopsy results could not be obtained by the Mohs surgeon using reasonable effort. The clinical record must clearly show that this situation existed.

Current accepted diagnoses and indications for MMS are:

Basal cell carcinomas, squamous cell carcinomas or basalosquamous cell carcinomas in anatomic locations where they are prone to recur:

• Central facial areas, nose and temple areas of the face (the so-called "mask area" of the face), which includes the eyebrows and periorbital areas, the superolateral temple areas, and the preauricular and postauricular areas.

• Lips, cutaneous and vermilion.

• Eyelids.

• The entire external ear and ear canal.

Other skin lesions:

• Angiosarcoma of the skin.

• Keratoacanthoma, recurrent or rapidly growing destructive variants.

• Dermatofibrosarcoma protuberans.

• Malignant fibrous histiocytoma.

• Sebaceous gland carcinoma.

• Microcystic adnexal carcinoma.

• Extramammary Paget's disease.

• Bowenoid papulosis.

• Merkel cell carcinoma.

• Bowen's disease (squamous cell carcinoma in situ).

• Adenoid type of squamous cell carcinoma.

• Rapid growth in a squamous cell carcinoma.

• Longstanding duration of a squamous cell carcinoma.

• Verrucous carcinoma.

• Atypical fibroxanthoma.

• Leiomyosarcoma or other spindle cell neoplasms of the skin.

• Adenoid Cystic carcinoma of the skin.

• Erythroplasia of Queyrat.

• Oral and central facial, and paranasal sinus neoplasm.

• Apocrine carcinoma of the skin.

• Malignant melanoma or melanoma in situ (facial, auricular, genital and digital) when anatomical or technical difficulties do not allow conventional excision with appropriate margins.

• Rare, biopsy-proven skin malignancies not otherwise addressed in this section.

• Basal cell carcinomas, squamous cell carcinomas or basalosquamous cell carcinomas having one or more of the following features:

• Are recurrent.

• Biopsy proven lesions with aggressive pathology as documented by at least 1 of the following microscopic characteristics:

• Sclerotic.

• Fibrosing.

• Morphea-like.

• Metatypical/infiltrative/spikey shaped cell groups.

• Perineural or perivascular invasion.

• Nuclear pleomorphism.

• High mitotic activity or superficial multicentric.

• Located in the following areas: genitalia, digits or nail unit/periungual.

• Large size (1.0 cm or greater in the non-mask areas of the face and 2.0 cm or greater in other areas).

• Positive margins on recent excision.

• Poorly defined borders.

• Present in the very young (less than 40 years of age).

• Radiation-induced.

• In patients with proven difficulty with skin cancers or who are immunocompromised.

• Basal cell nevus syndrome.

• Present in an old scar (e.g., Marjolin's ulcer).

• Associated with xeroderma pigmentosum or difficulty estimating depth of lesion.

• Laryngeal carcinoma in certain limited clinical situations.

Summary of evidence (opening)

N/A

The contractor cites 7 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2023-11-16
Last reviewed by the contractor
2023-10-10
MCD version
38
Derived from
L31749

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Palmetto GBA hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L33436 cover?

Medicare will consider reimbursement for Mohs micrographic surgery (MMS) for accepted diagnoses and indications. Current accepted diagnoses and indications are listed in this LCD. The physician performing the MMS must be trained and highly skilled in MMS techniques, and pathology identification. The physician must document in the patient's medical record that the diagnosis is appropriate for MMS and that MMS is… The full 596-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L33436 apply to?

Palmetto GBA applies it to Medicare claims in 7 states: AL, GA, NC, SC, TN, VA, WV. It binds only that contractor; 5 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L33436?

The companion billing and coding article A56732 lists 176 ICD-10-CM codes in 1 group that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L33436?

A denial under LCD L33436 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A56732's 176 covered diagnosis codes, then file a redetermination with Palmetto GBA within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.